Periscope Capital’s New Frontier Health Corporation Warrants, each whole warrant exercisable for one Ordinary Share at a NFH.WS Stock Holding History

Periscope Capital’s Portfolio NFH.WS Stock Details NFH.WS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-50,000	Closed	-$76K	–	253
2019 Q4	$76K	Buy	+50,000	New	+$70.5K	0.01%	189

Other funds holding NFH.WS

Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return

BCM

BlueCrest Capital Management St Helier, Jersey $3.04B AUM 26.78% 1-Year Est. Return

AGC

Angelo Gordon & Co New York $1.06B AUM 47.95% 1-Year Est. Return

WCA

Windsor Creek Advisors Bethel, Vermont $331M AUM 13.34% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

WAM

Weiss Asset Management Boston, Massachusetts $9.54B AUM 55.06% 1-Year Est. Return

AQR Arbitrage Greenwich, Connecticut $7.02B AUM 31.58% 1-Year Est. Return

GCL

Glazer Capital LLC New York $4.07B AUM 78.71% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Linden Advisors New York $19.3B AUM 1.47% 1-Year Est. Return

Periscope Capital's NFH.WS Position: Q1 2020 in Review

Periscope Capital sold out of New Frontier Health Corporation Warrants, each whole warrant exercisable for one Ordinary Share at a (NFH.WS) in Q1 2020, closing a stake of 50,000 shares — an estimated $76K sold.

Periscope Capital first reported a position in NFH.WS in Q4 2019 and held it in 1 quarter. The position peaked at $76K in Q4 2019. 19 funds tracked by Wall St. Rank hold NFH.WS as of Q1 2020.

Periscope Capital reported no remaining New Frontier Health Corporation Warrants, each whole warrant exercisable for one Ordinary Share at a position as of Q1 2020 after selling out during the quarter.
Periscope Capital sold 50,000 New Frontier Health Corporation Warrants, each whole warrant exercisable for one Ordinary Share at a shares in Q1 2020, an estimated $76K.
Periscope Capital first reported a position in New Frontier Health Corporation Warrants, each whole warrant exercisable for one Ordinary Share at a in Q4 2019 and held it in 1 quarter.
Periscope Capital's New Frontier Health Corporation Warrants, each whole warrant exercisable for one Ordinary Share at a position peaked at $76K in Q4 2019.
19 funds tracked by Wall St. Rank held New Frontier Health Corporation Warrants, each whole warrant exercisable for one Ordinary Share at a as of Q1 2020.

Based on Periscope Capital's 13F filing for Q1 2020, filed 14 May 2020.